PDF(Pubmed)
Abstract：
Small-cell neuroendocrine carcinoma (SCNEC) of the ovary is a gynecological malignancy characterized by rapid progression and poor prognosis. SCNEC is divided into primary and metastatic tumor. Primary ovarian neuroendocrine cancer is extremely rare and has a low 5-year survival rate. This paper reports the clinical manifestations of a 58-year-old patient with primary ovarian Small-cell neuroendocrine carcinoma and the prognosis after surgical adjuvant chemotherapy. The prevailing literature on this carcinoma is also reviewed and summarized. Our analysis reveals that histopathological examination is the standard diagnostic tool for ovarian SCNEC. We also highlight the importance of comprehensive imaging evaluation, early pathological diagnosis and comprehensive aggressive treatment to the prognosis of patients.
摘要：
卵巢小细胞神经内分泌癌（SCNEC）是一种妇科恶性肿瘤，其特征是进展迅速，预后不良。SCNEC分为原发性和转移性肿瘤。原发性卵巢神经内分泌癌极为罕见，5年生存率低。本文报告1例58岁原发性卵巢小细胞神经内分泌癌患者的临床表现及手术辅助化疗后的预后。还对该癌症的流行文献进行了回顾和总结。我们的分析表明，组织病理学检查是卵巢SCNEC的标准诊断工具。我们还强调了综合影像学评估的重要性，早期病理诊断和综合积极治疗对患者预后有影响。
